[unable to retrieve full-text content]
Powered by WPeMatico
WASHINGTON (Reuters) – U.S. Republicans on Tuesday fell short yet again in their seven-year drive to repeal Obamacare, in a bitter defeat that raises more questions about their ability to enact President Donald Trump’s agenda.
The party was unable to win enough support from its own senators for a bill to repeal the 2010 Affordable Care Act and decided not to put it to a vote, several Republicans said. The bill’s sponsors vowed to try again, but face steeper odds after Sunday, when special rules expire that allow them to pass healthcare legislation without Democratic support.
WASHINGTON (Reuters) – U.S. President Donald Trump said on Wednesday he was “not happy” with Health and Human Services Secretary Tom Price amid reports he used expensive private charter jets to travel for government business rather than cheaper commercial flights.
Asked if he would fire Price, Trump told reporters, “We’ll see.”
The House of Representatives Oversight and Government Reform Committee opened an investigation this week into travel by top U.S. officials.
Asked if he had confidence in Price after the reports on his travel, Trump said, “I am looking at that very closely. I am not happy with it. I will tell you I am not happy with it.”
September 26, 2017
Two drugs, already approved for safe use in people, may be able to improve therapy for chronic myeloid leukemia (CML), a blood cancer that affects myeloid cells, according to results from a University of Iowa study in mice.
CML is a relatively common cancer. The American Cancer Society estimates that in 2017 there will be about 8,950 new cases and about 1,080 people will die of the disease.
Teenagers and young adults with severe autism are spending weeks or even months in emergency rooms and acute-care hospitals, sometimes sedated, restrained or confined to mesh-tented beds, a Kaiser Health News investigation shows.
These young people — who may shout for hours, bang their heads on walls or lash out violently at home — are taken to the hospital after community social services and programs fall short and families call 911 for help, according to more than two dozen interviews with parents, advocates and physicians in states from Maine to California.
“Kill the bill, don’t kill us,” one woman screamed, inches from a U.S. Capitol Police officer’s face Monday afternoon in a marbled hallway of the U.S. Capitol at the start of the one and only public hearing on the GOP’s last-ditch effort to replace the Affordable Care Act.
The protesters had begun lining up at 5:30 a.m. — some paid others to hold their places — and by 2 p.m., hundreds of people were waiting for a coveted seat for the Senate Finance Committee’s hearing in Room 215 of the Dirksen Senate Office Building. Around lunchtime, Sen. Ron Wyden (D-Ore.) strolled through, passing out slices of pizza to some in line.
WASHINGTON (Reuters) – A Republican attempt to dismantle Obamacare fell apart in the U.S. Senate on Tuesday for the second time in two months in a serious defeat for President Donald Trump’s domestic agenda.
The party was unable to win enough support from its own senators for a bill to repeal the 2010 healthcare law and decided not to put it to a vote, several Republicans said.
“We basically ran out of time,” said Senator Ron Johnson, a co-sponsor of the measure with Senators Bill Cassidy and Lindsey Graham, who told reporters the party would target healthcare again after trying to reform the U.S. tax code.
PARIS (Reuters) – More than three decades after links emerged between Sanofi’s epilepsy drug valproate and birth defects, many pregnant women remain unaware of the risks, patients, doctors and researchers said on Tuesday.
Prescribed globally for epilepsy and bipolar disorders – and in some cases migraines – valproate is included in the World’s Health Organisation list of essential medicines.
But the drug is also known to have caused birth malfunctions and slow neurological development after being taken during pregnancy.
Of all the promises President Donald Trump made for the early part of his term, controlling stinging drug prices might have seemed the easiest to achieve.
An angry public overwhelmingly wants change in an easily vilified industry. Big pharma’s recent publicity nightmare included thousand-percent price increases and a smirking CEO who said, “I liken myself to the robber barons.” Even powerful members of Congress from both parties have said that drug prices are too high.
But any momentum to address prescription drug costs — a problem that a large number of Americans now believe government should solve — has been lost amid rancorous debates over replacing Obamacare and stalled by roadblocks erected via lobbying and industry cash.